Acurx Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $2.5M |
| Jun 2020 | — | — | $2.0M |
| Sep 2020 | — | — | $3.4M |
| Dec 2020 | — | $2.7M | $3.2M |
| Mar 2021 | — | $2.5M | $2.6M |
| Jun 2021 | — | $15.5M | $17.1M |
| Sep 2021 | — | $14.3M | $14.5M |
| Dec 2021 | — | $12.4M | $13.0M |
| Mar 2022 | — | $10.7M | $11.1M |
| Jun 2022 | — | $8.8M | $9.1M |
| Sep 2022 | — | $9.8M | $10.6M |
| Dec 2022 | — | $7.3M | $9.1M |
| Mar 2023 | — | $5.3M | $7.2M |
| Jun 2023 | — | $6.2M | $9.1M |
| Sep 2023 | — | $3.9M | $7.1M |
| Dec 2023 | — | $4.7M | $7.5M |
| Mar 2024 | — | $6.0M | $8.9M |
| Jun 2024 | — | $3.4M | $6.4M |
| Sep 2024 | — | $2.7M | $5.8M |
| Dec 2024 | — | $615.1K | $3.7M |
| Mar 2025 | — | $2.3M | $4.6M |
| Jun 2025 | — | $3.6M | $6.1M |
| Sep 2025 | — | $3.6M | $5.9M |
| Dec 2025 | — | $5.3M | $7.6M |
| Mar 2026 | — | $7.0M | $9.3M |
| Jun 2026 | — | $8.2M | $10.7M |